KT-1002

N/A

Report date: 2024/11/18 16:52:58
NME

Base Information

Drug NameKT-1002
Drug Alias NameKT-1002BC-1261BC-1215BC-1216
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFBX3 inhibitors
TargetsFBX3
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of PittsburghDepartment Of Veterans Affairs
China Registration ClassN/A

Develop Information

Active CompaniesDepartment Of Veterans AffairsUniversity Of PittsburghKoutif Therapeutics
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A